Filing Details
- Accession Number:
- 0001624794-24-000096
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2024-11-15 17:13:46
- Reporting Period:
- 2024-11-15
- Accepted Time:
- 2024-11-15 17:13:46
- SEC Url:
- Form 4 Filing
Issuer
Cik | Name | Symbol | Sector (SIC) | IRS No |
---|---|---|---|---|
1624794 | Csw Industrials Inc. | CSWI | () | 4 |
Insiders
Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
---|---|---|---|---|---|---|---|
1413614 | B Joseph Armes | 5420 Lyndon B Johnson Fwy Ste. 500 Dallas TX 75240-1007 | Chairman, President & Ceo | Yes | Yes | No | No |
Reported Non-Derivative Transactions
Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|---|---|---|---|---|---|
Common Stock | Disposition | 2024-11-15 | 156 | $403.38 | 51,542 | No | 4 | S | Direct | |
Common Stock | Disposition | 2024-11-15 | 579 | $404.35 | 50,963 | No | 4 | S | Direct | |
Common Stock | Disposition | 2024-11-15 | 117 | $405.35 | 50,846 | No | 4 | S | Direct | |
Common Stock | Disposition | 2024-11-15 | 62 | $406.94 | 50,784 | No | 4 | S | Direct | |
Common Stock | Disposition | 2024-11-15 | 78 | $407.94 | 50,706 | No | 4 | S | Direct | |
Common Stock | Disposition | 2024-11-15 | 8 | $408.96 | 50,698 | No | 4 | S | Direct |
Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|
No | 4 | S | Direct | |
No | 4 | S | Direct | |
No | 4 | S | Direct | |
No | 4 | S | Direct | |
No | 4 | S | Direct | |
No | 4 | S | Direct |
Reported Non-Derivative Holdings
Sec. Name | Remaning Holdings | Nature of Ownership | Explanation |
---|---|---|---|
Common Stock | 1,500 | Indirect | JBA Family Partners, L.P. |
Common Stock | 3,142 | Indirect | by ESOP |
Reported Derivative Holdings
Sec. Name | Sec. Type | Price | Date | Expiration Date | Amount | Remaning Holdings | Nature of Ownership |
---|---|---|---|---|---|---|---|
Common Stock | Performance Rights | $0.00 | 8,236 | 8,236 | Direct | ||
Common Stock | Performance Rights | $0.00 | 12,422 | 12,422 | Direct | ||
Common Stock | Performance Rights | $0.00 | 7,851 | 7,851 | Direct | ||
Common Stock | Performance Rights | $0.00 | 27,559 | 27,559 | Direct | ||
Common Stock | Restricted Stock Units | $0.00 | 19,685 | 19,685 | Direct |
Expiration Date | Amount | Remaning Holdings | Nature of Ownership |
---|---|---|---|
8,236 | 8,236 | Direct | |
12,422 | 12,422 | Direct | |
7,851 | 7,851 | Direct | |
27,559 | 27,559 | Direct | |
19,685 | 19,685 | Direct |
Footnotes
- The transaction reported was effected pursuant to a 10b5-1 trading plan established by the reporting person on November 17, 2023.
- The price reported is a weighted average price. These shares were sold in multiple transactions at prices ranging from $402.71 to $403.71, inclusive. The reporting person undertakes to provide to the issuer, any security holder of the issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range.
- The price reported is a weighted average price. These shares were sold in multiple transactions at prices ranging from $403.91 to $404.90, inclusive. The reporting person undertakes to provide to the issuer, any security holder of the issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range.
- The price reported is a weighted average price. These shares were sold in multiple transactions at prices ranging from 405.17 to $405.68, inclusive. The reporting person undertakes to provide to the issuer, any security holder of the issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range.
- The price reported is a weighted average price. These shares were sold in multiple transactions at prices ranging from $406.83 to $407.03, inclusive. The reporting person undertakes to provide to the issuer, any security holder of the issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range.
- The price reported is a weighted average price. These shares were sold in multiple transactions at prices ranging from $407.85 to $408.03, inclusive. The reporting person undertakes to provide to the issuer, any security holder of the issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range.
- Each performance right represents a contingent right to receive one share of the issuer's common stock at vesting. The performance rights vest at a rate between 0% and 200% during a three-year performance cycle beginning on April 1, 2024 and ending on March 31, 2027 based on the issuer's relative total shareholder return in comparison to the total shareholder return performance among the Russell 2000 Index over the performance cycle. The performance rights may be settled, at the issuer's discretion, in cash or shares of common stock.
- Each performance right represents a contingent right to receive one share of the issuer's common stock at vesting. The performance rights vest at a rate between 0% and 200% during a three-year performance cycle beginning on April 1, 2023 and ending on March 31, 2026 based on the issuer's relative total shareholder return in comparison to the total shareholder return performance among the Russell 2000 Index over the performance cycle. The performance rights may be settled, at the issuer's discretion, in cash or shares of common stock.
- Each performance right represents a contingent right to receive one share of the issuer's common stock at vesting. The performance rights vest at a rate between 0% and 200% during a three-year performance cycle beginning on April 1, 2022 and ending on March 31, 2025 based on the issuer's relative total shareholder return in comparison to the total shareholder return performance among the Russell 2000 Index over the performance cycle. The performance rights may be settled, at the issuer's discretion, in cash or shares of common stock.
- Each performance right represents a contingent right to receive one share of the issuer's common stock at vesting. The performance rights vest in three equal amounts, at a rate between 0% and 200%, during three performance cycles ending on each of March 31, 2025, 2026, and 2027 based on the issuer's relative total shareholder return in comparison to the total shareholder return performance among the Russell 2000 Index over the performance cycle. The performance rights may be settled, at the issuer's discretion, in cash or shares of common stock.
- Each restricted stock unit represents a contingent right to receive one share of the issuer's common stock at vesting. 40% of the restricted stock units vest no earlier than April 26, 2025 upon the successful recruitment and hiring of a successor Chief Executive Officer; the remaining 60% vest upon the successful first employment anniversary of a successor Chief Executive Officer.